We are excited to be exhibiting at DDL 2023, an event focusing on respiratory drug delivery, taking place December 6-8, 2023 in Edinburgh, Scotland.
Drug Delivery to the Lungs (DDL) conference is the premier international conference covering all aspects of respiratory drug delivery. The event offers opportunities to attend lectures as well as view posters and exhibitions, facilitating networking opportunities for attendees, presenters and exhibitors.
We are thrilled to be exhibiting at DDL 2023, as we showcase our expansive inhalation offering across all three days of the event.
Recipharm offers a fully integrated service for developing and manufacturing inhalation drug products and devices to the global pharmaceutical market, including pressurised Metered Dose Inhalers (pMDIs), Soft Mist Inhalers (SMIs), Dry Powder Inhalers (DPIs), unit dose and multi dose nasal sprays.
Recipharm has a long history in inhalation device design & development and manufacturing. By developing inhalation products with the device and commercial manufacture in mind we minimise hurdles and reduce time to market.
If you would like to learn more about our inhalation offerings, arrange a meeting with us at DDL 2023.